Good news for R-PLUS Curcumin:
A recent study examined the ability to prevent damage to the liver against chronic hepatitis in a rat model using curcumin and R-lipoic acid. Glutathione depletion, collagen deposition, macrophage activation and nuclear factor κappa-B expression as well as tumour necrosis factor-α and interleukin-6 levels were significantly decreased in response to administration of these supplements.
Serological analysis of liver function and liver histopathological examination reinforced the results. The above evidence collectively indicates that the antioxidant and anti-inflammatory activities of curcumin and R-lipoic acid may confer therapeutic efficacy against chronic hepatitis.
